These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
131 related items for PubMed ID: 16151649
1. Downregulation of Apaf-1 and caspase-3 by RNA interference in human glioma cells: consequences for erucylphosphocholine-induced apoptosis. Kugler W, Buchholz F, Köhler F, Eibl H, Lakomek M, Erdlenbruch B. Apoptosis; 2005 Oct; 10(5):1163-74. PubMed ID: 16151649 [Abstract] [Full Text] [Related]
2. MAP kinase pathways involved in glioblastoma response to erucylphosphocholine. Kugler W, Erdlenbruch B, Otten K, Jendrossek V, Eibl H, Lakomek M. Int J Oncol; 2004 Dec; 25(6):1721-7. PubMed ID: 15547710 [Abstract] [Full Text] [Related]
3. Intracellular mediators of erucylphosphocholine-induced apoptosis. Jendrossek V, Müller I, Eibl H, Belka C. Oncogene; 2003 May 01; 22(17):2621-31. PubMed ID: 12730676 [Abstract] [Full Text] [Related]
4. Increased cytotoxicity of ionizing radiation in combination with membrane-targeted apoptosis modulators involves downregulation of protein kinase B/Akt-mediated survival-signaling. Handrick R, Rübel A, Faltin H, Eibl H, Belka C, Jendrossek V. Radiother Oncol; 2006 Aug 01; 80(2):199-206. PubMed ID: 16916558 [Abstract] [Full Text] [Related]
5. Topotecan triggers apoptosis in p53-deficient cells by forcing degradation of XIAP and survivin thereby activating caspase-3-mediated Bid cleavage. Tomicic MT, Christmann M, Kaina B. J Pharmacol Exp Ther; 2010 Jan 01; 332(1):316-25. PubMed ID: 19812371 [Abstract] [Full Text] [Related]
6. Bcl-2 mediated inhibition of erucylphosphocholine-induced apoptosis depends on its subcellular localisation. Handrick R, Rudner J, Müller I, Eibl H, Belka C, Jendrossek V. Biochem Pharmacol; 2005 Sep 15; 70(6):837-50. PubMed ID: 16083863 [Abstract] [Full Text] [Related]
7. Histone deacetylase activity regulates apaf-1 and caspase 3 expression in the developing mouse retina. Wallace DM, Donovan M, Cotter TG. Invest Ophthalmol Vis Sci; 2006 Jul 15; 47(7):2765-72. PubMed ID: 16799012 [Abstract] [Full Text] [Related]
8. Bax and Bid act in synergy to bring about T11TS-mediated glioma apoptosis via the release of mitochondrial cytochrome c and subsequent caspase activation. Bhattacharjee M, Acharya S, Ghosh A, Sarkar P, Chatterjee S, Kumar P, Chaudhuri S. Int Immunol; 2008 Dec 15; 20(12):1489-505. PubMed ID: 18931364 [Abstract] [Full Text] [Related]
9. Downregulation of Bid is associated with PKCepsilon-mediated TRAIL resistance. Sivaprasad U, Shankar E, Basu A. Cell Death Differ; 2007 Apr 15; 14(4):851-60. PubMed ID: 17186022 [Abstract] [Full Text] [Related]
10. Apoptosis protease activator protein-1 expression is dispensable for response of human melanoma cells to distinct proapoptotic agents. Zanon M, Piris A, Bersani I, Vegetti C, Molla A, Scarito A, Anichini A. Cancer Res; 2004 Oct 15; 64(20):7386-94. PubMed ID: 15492260 [Abstract] [Full Text] [Related]
11. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells. Sylvester PW, Shah S. Asia Pac J Clin Nutr; 2005 Oct 15; 14(4):366-73. PubMed ID: 16326643 [Abstract] [Full Text] [Related]
12. Erucylphosphocholine-induced apoptosis in chemoresistant glioblastoma cell lines: involvement of caspase activation and mitochondrial alterations. Jendrossek V, Kugler W, Erdlenbruch B, Eibl H, Lang F, Lakomek M. Anticancer Res; 2001 Oct 15; 21(5):3389-96. PubMed ID: 11848499 [Abstract] [Full Text] [Related]
13. Modification of gene products involved in resistance to apoptosis in metastatic colon cancer cells: roles of Fas, Apaf-1, NFkappaB, IAPs, Smac/DIABLO, and AIF. Huerta S, Heinzerling JH, Anguiano-Hernandez YM, Huerta-Yepez S, Lin J, Chen D, Bonavida B, Livingston EH. J Surg Res; 2007 Sep 15; 142(1):184-94. PubMed ID: 17603079 [Abstract] [Full Text] [Related]
14. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells. Dong K, Wang R, Wang X, Lin F, Shen JJ, Gao P, Zhang HZ. Breast Cancer Res Treat; 2009 Feb 15; 113(3):443-56. PubMed ID: 18327707 [Abstract] [Full Text] [Related]
15. Inhibition of hepatitis C virus core protein expression in immortalized human hepatocytes induces cytochrome c-independent increase in Apaf-1 and caspase-9 activation for cell death. Meyer K, Basu A, Saito K, Ray RB, Ray R. Virology; 2005 Jun 05; 336(2):198-207. PubMed ID: 15892961 [Abstract] [Full Text] [Related]
16. Resistance to fas-induced apoptosis in cells from human atherosclerotic lesions: elevated Bcl-XL inhibits apoptosis and caspase activation. Yang Z, Gagarin D, Ramezani A, Hawley RG, McCaffrey TA. J Vasc Res; 2007 Jun 05; 44(6):483-94. PubMed ID: 17657164 [Abstract] [Full Text] [Related]
17. Reconstitution of caspase 3 sensitizes MCF-7 breast cancer cells to doxorubicin- and etoposide-induced apoptosis. Yang XH, Sladek TL, Liu X, Butler BR, Froelich CJ, Thor AD. Cancer Res; 2001 Jan 01; 61(1):348-54. PubMed ID: 11196185 [Abstract] [Full Text] [Related]
19. The novel phospholipase C activator, m-3M3FBS, induces apoptosis in tumor cells through caspase activation, down-regulation of XIAP and intracellular calcium signaling. Jung EM, Lee TJ, Park JW, Bae YS, Kim SH, Choi YH, Kwon TK. Apoptosis; 2008 Jan 01; 13(1):133-45. PubMed ID: 18060503 [Abstract] [Full Text] [Related]
20. Erucylphosphocholine shows a strong anti-growth activity in human endometrial and ovarian cancer cells. Takai N, Ueda T, Nasu K, Narahara H. Gynecol Oncol; 2008 Nov 01; 111(2):336-43. PubMed ID: 18790523 [Abstract] [Full Text] [Related] Page: [Next] [New Search]